Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.14%3.11B | 41.81%549.47M | 15.84%603.39M | 15.89%2.9B | 2.80%840.8M | 106.97%1.15B | -44.23%387.48M | 19.99%520.88M | 15.60%2.5B | 0.26%817.87M |
Cost of revenue | 2.49%2.22B | 20.62%370.84M | -8.34%400.89M | 17.97%2.16B | -13.51%526.62M | 105.54%892.17M | -35.75%307.44M | 39.92%437.38M | 19.32%1.83B | 0.97%608.87M |
Gross profit | 20.77%890.52M | 123.21%178.64M | 142.54%202.5M | 10.18%737.34M | 50.33%314.18M | 112.02%259.63M | -62.99%80.03M | -31.30%83.49M | 6.52%669.22M | -1.75%209M |
Operating expense | 21.22%528.33M | 14.40%128.06M | 23.43%132.42M | 9.25%435.84M | 7.13%107.88M | 10.62%108.74M | 14.88%111.94M | 4.66%107.28M | 0.37%398.94M | 7.16%100.69M |
Operating profit | 20.13%362.2M | 258.52%50.58M | 394.59%70.08M | 11.55%301.51M | 90.49%206.31M | 524.54%150.9M | -126.86%-31.91M | -225.07%-23.79M | 17.11%270.28M | -8.80%108.31M |
Net non-operating interest income (expenses) | 64.98%-208K | 50.97%-76K | 46.52%-100K | 39.45%-594K | 45.50%-115K | 41.95%-137K | 37.50%-155K | 34.62%-187K | 27.71%-981K | 30.36%-211K |
Non-operating interest income | 1,150.00%100K | ---- | ---- | -27.27%8K | 33.33%4K | --0 | ---- | ---- | -42.11%11K | -66.67%3K |
Non-operating interest expense | -48.84%308K | -49.06%81K | -46.52%100K | -39.31%602K | -44.39%119K | -41.95%137K | -37.89%159K | -34.62%187K | -27.91%992K | -31.41%214K |
Net investment income | -6.86%652K | 0 | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -146.09%-315K | -79K | -79K | -128K | 0 | 0 | 0 | |||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 513K | 0 | 0 | |||||||
Less:Other special charges | ---513K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 90.26%-489K | -56.60%924K | 97.92%-147K | 33.60%-5.02M | 99.22%-64K | 22.50%-31K | 216.34%2.13M | -35,385.00%-7.06M | -1,390.96%-7.57M | -2,468.30%-8.22M |
Income before tax | 22.29%361.7M | 269.92%50.86M | 324.77%69.75M | 12.72%295.76M | 106.26%206M | 529.10%150.73M | -125.07%-29.93M | -262.07%-31.03M | 18.03%262.38M | -9.65%99.88M |
Income tax | 17.30%105.87M | 292.90%15.24M | 314.69%23.66M | 14.74%90.26M | 109.58%62.7M | 565.41%46.47M | -121.94%-7.9M | -291.29%-11.02M | 36.84%78.66M | -18.64%29.92M |
Net income | 24.49%255.82M | 261.68%35.62M | 330.33%46.1M | 11.86%205.5M | 104.84%143.3M | 514.12%104.25M | -126.42%-22.03M | -249.50%-20.01M | 11.47%183.72M | -5.17%69.96M |
Net income continuous operations | 24.49%255.82M | 261.68%35.62M | 330.33%46.1M | 11.86%205.5M | 104.83%143.3M | 514.16%104.25M | -126.42%-22.03M | -249.50%-20.01M | 11.47%183.72M | -5.17%69.96M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 24.49%255.82M | 261.68%35.62M | 330.33%46.1M | 11.86%205.5M | 104.84%143.3M | 514.12%104.25M | -126.42%-22.03M | -249.50%-20.01M | 11.47%183.72M | -5.17%69.96M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 24.49%255.82M | 261.68%35.62M | 330.33%46.1M | 11.86%205.5M | 104.84%143.3M | 514.12%104.25M | -126.42%-22.03M | -249.50%-20.01M | 11.47%183.72M | -5.17%69.96M |
Gross dividend payment | ||||||||||
Basic earnings per share | 25.82%40.06 | 263.16%5.58 | 330.35%7.21 | 5.78%31.84 | 93.37%22.16 | 483.81%16.23 | -125.02%-3.42 | -242.92%-3.13 | 7.38%30.1 | -8.39%11.46 |
Diluted earnings per share | 27.11%39.48 | 260.71%5.5 | 326.84%7.1 | 7.44%31.06 | 96.73%21.66 | 497.63%15.9567 | -126.08%-3.4223 | -248.34%-3.13 | 12.10%28.91 | -4.84%11.01 |
Dividend per share | 10 | |||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |